Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Imaging Canada Liquidating Corp IMRSQ

IMRIS Inc designs, manufactures and markets Image-guided therapy systems that improves the effectiveness of therapy delivery. Its main product is the Visius surgical theater. The company provides its products to hospitals that deliver clinical services to patients in the neurosurgical, spinal, cerebrovascular and cardiovascular markets. The firm is focused on bringing enhanced visualization to the point of therapy delivery and is spread across Canada, United States, Europe and the Middle East and Asia-Pacific.


GREY:IMRSQ - Post by User

Post by erasmus2010on Jan 17, 2013 11:02am
151 Views
Post# 20850853

VISIUS Wireless Coil 510(k) FDA Approval

VISIUS Wireless Coil 510(k) FDA Approval

Link to FDA approval document December 27, 2012.

Will produce some recuring revenue and simplify operatering room procedures.

This is the first FDA approval for a wireless coil and is for both 1.5T and 3.0T Imris/Siemens MRI systems. It is substantially equivalent to previously approved Imris head coils.

https://www.accessdata.fda.gov/cdrh_docs/pdf12/K123091.pdf

 

<< Previous
Bullboard Posts
Next >>